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Abstract Mitochondria produce cellular energy but
also free-radicals, which damage cells despite an array
of endogenous anti-oxidants. In Northern Europe, the
mitochondrial haplogroup J has been related to lon-
gevity in nonagenarians and centenarians but also with
age-related disease. Hypertension is an important
contributor to atherosclerotic-related diseases and its
pathogenesis is associated with increased oxidative
stress. In this study, we questioned whether J hap-
logroup octo/nonagenarians from the Belfast Elderly
Longitudinal Free-living Elderly STudy (BELFAST)
study showed evidence of protective blood pressure or
anti-oxidant profile which might explain their longev-
ity advantage. Briefly, in a cross-sectional study,
community-living, mentally alert (Folstein >25/30),
octo/nonagenarian subjects, recruited for good health,
were enlisted and consented as part of the BELFAST
study, for blood pressure, anthropometric measurements
and blood sampling. DNA typing for mitochondrial
haplotypes was carried out with measurements for en-
zymatic and non-enzymatic antioxidants. J haplogroup
carriers showed lower systolic blood pressure and glu-
tathione peroxidase activity (Gpx) with higher folate
measurements. There was no change in urate, bilirubin,
albumin or nutrition-related antioxidants-selenium or
vitamins A, C and α and β carotene. BELFAST study
mtDNA J haplogroup octo/nonagenarians showed
lower blood pressure and reduced glutathione peroxi-
dase activity and higher folate, but no change for other
antioxidants. These findings are of interest in view of
mtDNA J haplogroup’s association with increased age
in some previous studies.
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Introduction
Mitochondria undertake multiple critical functions in a
cell. They are the chief source of efficient energy
production in cells, converting glucose into numerous
high-energy phosphate bonds which transform adeno-
sine diphosphate (ADP) to adenosine triphosphate
(ATP) along the electron cascade. In addition to gener-
ating much of the cellular energy, mitochondria regulate
the cellular redox state, produce most of the cellular
reactive oxygen species (ROS), buffer cellular Ca2+
and initiate cellular apoptosis. Mitochondria have limit-
ed protection from oxidative stress (Wallace 1992) and
energy production comes at the price of free radical
production which risks damaging DNA, proteins, lipids
and carbohydrates within the mitochondria, the cyto-
plasm, nucleus and cell membrane, with knock-on neg-
ative effects on cellular transcription and metabolic
pathways (Gómez and Hagen 2012). As a counter-
balancing mechanism, the cell has a range of enzymatic
(glutathione peroxidase, catalase and superoxide dismu-
tase), non-enzymatic (glutathione, albumin, bilirubin
and uric acid) (Meister 1994) and nutrition-related anti-
oxidant mechanisms (vitamins A, E and C together with
selenium), (Padayatty et al. 2003; Dragsted et al. 2004)
which together and separately, help minimise oxidative
damage (Miquel 2002).
As we age, the free radical theory of ageing (Harman
1956) suggests that cells become less efficient at
managing cellular damage, because the burden of
damage becomes too great, there is inadequate antioxi-
dant capacity, compromised nutrition or a combination
of all three. The patho-physiology of a whole range of
human age-related and degenerative diseases as well as
cancer, have been held to be caused by an age-related
decline in our ability to manage our free radical damage
at the cellular level (Mueller et al. 2012; Mancuso et al.
2007; Chinnery et al. 2000; Cadenas and Davies 2000;
Harrison et al. 2003).
In animal studies, nuclear and mitochondrial genes
seem to both have an influence on the rate of ageing
and free radical burden. In mice with genetically in-
creased enzymatic anti-oxidant catalase activity, there
is evidence for reduced atherosclerosis and increased
lifespan (Cutler 2005) and mitochondrial-related
genes affect oxidative stress in mice (Thompson
2006). Unlike nuclear genes which are protected by
histones, mitochondria are extremely susceptible to
oxidative damage. Between 2 and 4 % of the oxygen
consumed by mitochondria is converted into superox-
ide anions by the electrode transport chain (Wallace
1992) with the consequence that mitochondrial muta-
tions are relatively common. These mutation differ-
ences can define people and population clusters and
their genetic heritage. Each person can be described by
a mitochondrial haplogroup which is defined by a
series of mutation changes which have been inherited
by groups of people or populations, albeit several
generations previously. Most Europeans are consid-
ered to derive from the main mitochondrial mitochon-
drial haplogroup root called R which has branching
subgroups of U (U5, U6, U2, U, U8 and K), V and H,
T and J, and B. The mitochondrial haplogroups J and
T therefore share the same sub-branch of R and are
considered to have been inherited from one woman,
who is thought to have belonged to the hunter–gath-
erers that colonised Europe thousands of years before
the agricultural revolution moved across Europe.
In extreme longevity, there is some suggestive ev-
idence that mutations in the mitochondrial genome
might play a role in ‘successful’ ageing. The Cauca-
sian haplogroup J is characterised by the mutations
T489C, A10398G, A1262G, G13708A plus the
T4216C, A11251G and C15452A substitutions which
are shared with haplogroup T. The J combination of
mutations seem to confer a higher chance of achieving
longevity than other mtDNA haplogroups in Northern
Italians (De Benedictis et al. 1999), Northern Irish
(Ross et al. 2001), Finns (Niemi et al. 2003) and
Northern Spaniards (Domínguez-Garrido et al. 2009)
but has have not been corroborated in Southern
Italians (Dato et al. 2004), in a Tunisian population
(Cherni et al. 2009) and in central Spaniards (Pinós et
al. 2012), suggesting that the J haplogroup association
may be population-specific. Other issues such as study
differences in the ethnic and geographic origins of
subjects and age differences of the ‘longevity’ cohorts
are also potential confounders, since some reports
studied centenarians (De Benedictis et al. 1999; Pinós
et al. 2012), other studies younger elders, i.e. 85+
years (Domínguez-Garrido et al. 2009); 80–97 years
(Ross et al. 2001) or 90–91 years (Niemi et al. 2003).
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In seeking a possible explanation for these varied
findings, Ruiz-Pesini et al. 2004, suggested that the clus-
tering of J mitochondrial haplogroups in colder northern
European climes might track with an evolutionary ad-
vantage relating to improved mitochondrial energy and
therefore heat production, but at the price of increased
anti-oxidant stress and the predilection for degenerative
diseases in unfavourable cellular environments. Along-
side the evidence relating the J mitochondrial haplogroup
with longevity, J and related haplogroups have converse-
ly also been variously associated with degenerative dis-
eases including Parkinsons disease (Ross et al. 2003;
Mancuso et al. 2007). Additionally, the mitochondrial
haplogroups are implicated in clinical manifestations
related to atherosclerosis or hypertension (Rosa et al.
2008; Rybka et al. 2011a). Both hypertension and
atherosclerosis are increasingly considered to have a
stress-related pathogenesis (Schnabel and Blankenberg
2007; Harrison et al. 2003) with broad evidence that
measures anti-oxidant status, e.g. glutathione peroxidase
activity (Gpx) may be increased in these situations or
conversely reduced where cardiovascular disease and
hypertension is minimal.
In this study, we tested the hypothesis that Belfast
Elderly Longitudinal Free-living Elderly STudy (BEL-
FAST) octo/nonagenarians carrying the mitochondrial J
haplogroup would show a better blood pressure and
antioxidant phenotype as a part explanation of their
good-quality longevity.We also carried out comparisons
of the T mitochondrial haplogroup which shares a sim-
ilar mitochondrial subgroup root as J, though a number
of additional mutations define a separate branch.
Methods and materials
Subject phenotype characteristics
Subjects
Elderly subjects were a consecutive mid-study cohort
enlisted from the BELFASTstudy, aged 80–100 years of
age (Rea 2010; Rea et al. 2009), who met SENIEUR
protocol (Ligthart et al. 1984). At recruitment, all sub-
jects were mentally alert (Folstein >25/30), (Folstein
and Folstein et al. 1975), apparently well and living in
the community. One hundred and twenty-nine elderly
subjects had DNA available for characterisation of J and
non-J mitochondrial haplogroups (Ross et al. 2001). A
flow diagram Fig. 1 shows the numbers of matching
anthropometric variables, biochemistry, haematological,
antioxidant and vitamin measurements which were
available for the subjects. Because of subject frailty or
inadequate samples, not all subjects have complete
matching data. All subjects gave written consent and
Ethical Consent for the study was obtained from Ethical
Committee of Queens University Belfast.
Blood pressure measurements and sample collection
Subjects were seen in their own homes by the trained
research officer and nurse. Blood pressure was mea-
sured in a sitting position and after 5 min of rest using
a mercury sphygmomanometer, following the recom-
mendations of the British Hypertension Society. Systol-
ic blood pressure and diastolic blood pressure were
measured using Korotkoff phase I and phase V, respec-
tively. Blood was collected from subjects at a morning
visit and returned to Belfast City Hospital Laboratories
within 1 h of collection for various analyses.
Methods
Glutathione (GSH) GSH blood samples, freshly col-
lected into metaphosphoric acid-containing tubes, were
transported in liquid nitrogen and stored at −70 °C until
analysis by High Performance liquid Chromatography.
Glutathione peroxidise Gpx was measured in serum
using a modification of the coupled assay of Paglia
and Valentine as described by McMaster et al. 1990.
Selenium in serum and whole blood Selenium in se-
rum and whole blood was measured by atomic absorp-
tion spectrophotometer (McMaster et al. 1990). The
intra-assay reproducibility for serum selenium showed
a coefficient of variation (CV) for between-runs of 5.7
and 4.4 % within run. For selenium in whole blood the
CV was 5.9 % between runs and 5.7 % within run.
Vitamins A, C and E and α and β carotene Vitamins
A, C and E and α and β carotene were measured in
serum collected and stored at −70 °C and measured by
standard methods (Ulker et al. 2004).
Uric acid and bilirubin Uric acid and bilirubin were
collected and routinely measured daily by Belfast City
Hospital automated multichannel analyser.
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Genotype characteristics
DNA separation, mitochondrial haplotyping and phy-
logenetic analysis DNA was separated from whole
blood by standard salting out method (Miller et al.
1988). Briefly, PCR primers employed for amplifica-
tion of the 2,643-bp region of interest in the mitochon-
drial genome were those described by Torroni et al.
(1994) but extended at the 5′ end to improve the
specificity and sensitivity of the PCR as noted previ-
ously (Ross et al. 2001; De Benedictis et al. 1999).
The phylogenetic relationships between the 46 hap-
logroups observed in this study were analysed using
maximum parsimony criteria, using the cluster of pro-
grammes in the PHYLIP package (Version 3.5c;
Felsenstein 1993) and as previously described (Ross
et al. 2001).
Statistical analysis
For each variable, values are expressed as mean and
standard deviation (SD) or as medians for non-normal
distributions. Subject age, biochemical variables, Gpx
activity and the other antioxidants were categorised by J
or non-J mitochondrial haplogroup status and analysed
by t test or Mann–Whitney U (mwu) as appropriate.
Blood pressure and a number of related variables were
also categorised and comparison made for T and non-T
mitochondrial haplogroups. Logistic regression analysis
and odds ratio (OR) was used to predict differences in
BELFASTudy
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blood pressure categories defined by mitochondrial
groups J non-J and T non-T and multiple models were
constructed and analysed to include variables signifi-
cantly different or close to significance in t test or mwu
or other analyses. A p value of <0.05 was regarded as
significant.
Results
Subject phenotype characteristics
Subjects
Subject characteristics are described in Tables 1, 2 and
3. Mean age was 89.6 [SD 4.6] years with no difference
between J and non-J mitochondrial haplogroup carriers.
Haemoglobin, white cell count, glucose, cholesterol and
measures of renal function were not different between J
and non-J haplogroup carriers. There was also no sig-
nificant difference for body mass index and cholesterol.
Medication and smoking
There were differences between the use of medications
across J and non-J mtDNA haplogroups. It was more
common for J mtDNA haplogroup carriers compared
to non-J mtDNA haplogroups to be on no medication,
overall 20 viz 10 %, respectively. Anti-hypertensive
use was 32 vs 32 % respectively and aspirin use 0 vs
14 % was more common in non-J mtDNA haplogroup
subjects compared to J mtDNA haplogroup subjects.
With respect to smoking there was little difference
in the categories of never, past and current smokers
between J and non-J mtDNA haplogroup carriers with
40 vs 50 % of subjects in J and non-J mtDNA groups
advising that they had never smoked, 20 vs 21 %
saying they had smoked in the past and 20 vs 21 %
saying they were current smokers.
Genotype characteristics
Mitochondrial J haplogroup and blood pressure
Mean systolic blood pressure across the octo/nonagenar-
ian group was 132 [standard deviation (SD) 17] mmHg,
with a significantly lower value (p00.02) for J hap-
logroup 122 [SD 14] compared to non-J haplogroups
136 [SD 18]. Diastolic blood pressure was also lower in J
haplogroup octo/nonagenarians, 76 [SD 14] mmHg,
compared with 82 [SD 12] mmHg, in non-J haplogroups
Table 2 and Fig. 2, but this difference just failed to reach
significance (p00.06). A similar pattern was represented
across male and female, J and non-J haplogroups for
both systolic and diastolic blood pressure, Fig. 3.
Mitochondrial T haplogroup and blood pressure
Systolic and diastolic blood pressure were not signif-
icantly different when categorised by mitochondrial
haplogroups T non-T; systolic blood pressure 133
[SD 11] and 134 [SD 18] p00.99 for T and non-T,
respectively, and for diastolic 84 [SD 5] and 81 [13]
p00.80, respectively (data not shown).
Mitochondrial J haplogroup and cellular anti-oxidants
Glutathione peroxidase activity in serum and blood
categorised according to J and non J haplogroup car-
rier is shown in Table 2. Mean glutathione peroxidase
activity in blood and serum was significantly lower in
J carriers (p00.03 and p00.01, respectively). There
Table 1 Phenotypic character-
istics of subjects categorised by J
and non-J mitochondrial
haplogroup
Number of subjects are in round
brackets, standard deviations are
in square brackets
BMI body mass index
J haplogroup Non-J haplogroup t test
Age, years 88.1 (13) [4.2] 89.9 (113) [4.5] 0.12
Sex 5F/8M 80F/33M
BMI, kg/m2 24.0 (12) [5.0] 23.8 (104) [3.7] 0.88
Glucose, μmol/l 5.6 (12) [1.2] 6.1 (97) [2.7] 0.54
Cholesterol 4.9 (12) [1.2] 5.5 (97) [1.1] 0.10
Urea, μmol/l 9.2 (12) [6.4] 7.3 (97) [2.6] 0.06
Haemoglobin, g/dl 13.0 (10) [1.2] 13.4 (71) [1.3] 0.29
White blood cell×109 8.1 (10) [3.9] 6.9 (71) [1.8] 0.10
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was no change in serum glutathione or selenium
between J and non-J carriers.
Non-enzymatic and nutrition-related antioxidants
and mitochondrial J haplogroups
The non-enzymatic antioxidants albumin, bilirubin and
urate were not significantly different when subjects were
categorised according to mitochondrial J haplogroup,
Table 3. Similarly there are no significant differences
for serum vitamins A and C and α and β carotenoids,
for J and non-J mitochondrial haplogroup carriers,
though numbers are small. Serum folate was significant-
ly higher in J compared to non J haplogroup carriers and
Vit E lower in the small number of J haplotype carriers.
Logistic regression
Logistic regression was used to further explore whether
carriage of the J or the non-J mitochondrial haplotype by
BELFASTocto/nonagenarians could predict blood pres-
sure and associated anti-oxidant status since logistic
regression does not depend on the normality of
independent variables nor the linearity of relationships.
Table 4 shows coefficients B, χ2 and associated p values
with Exp(B) as the odds ratio (OR), using J and non-J
mitochondrial status as a dichotomous variable for
prediction of blood pressure, Gpx and folate-variables
previously noted to be significantly different between
the J mitochondrial categories. For systolic blood pres-
sure, J carriers were predicted to be likely to have lower
blood pressure compared to non-J carriers by about 5
mms for each 100 mmHg (OR 0.95, confidence limits
CI 0.91–0.99; p00.017) which appeared to the confirm
findings from the preliminary comparative analyses. For
the anti-oxidant glutathione peroxidise activity, J mito-
chondrial carriers were also predicted to have somewhat
lower glutathione peroxidase activity (OR 0.98; CI
0.96–1.0; p00.027) in agreement with previous
findings. Folate by contrast showed a trend for higher
values in J haplotype carriers (OR01.12; CI 0.99–1.27;
Table 2 Systolic and diastolic
blood pressure, glutathione per-
oxidase activity, glutathione, and
selenium categorised by J and
non-J mitochondrial haplogroups
Number of subjects are in round
brackets, standard deviations are
in square brackets
Italic median and ω mwu
*p<0.05
J haplogroup Non-J haplogroup t test
Systolic blood pressure, mmHg 122 (13) [14] 136 (107) [18] 0.01*
Diastolic blood pressure, mmHg 76 (13) [14] 82 (107) [12] 0.08
Selenium μmol/l (serum) 0.75 (11) [0.23] 0.82 (89) [0.26] 0.41
Glutathione peroxidase activity (serum) 193 (7) [71] 259 (58) [55] 0.01*
186 256 0.03*
Glutathione peroxidase activity (blood) 3,694 (7) [822] 4,373 (58) [741] 0.03*
3,333 4,311 0.01* ω
Glutathione peroxidase activity/gmHg (blood) 32.3 (7) [3.3] 35.0 (58) [6.3] 0.31
Glutathione 9.9 (5) [2.5] 10.1 (30) [2.2] 0.89
Table 3 Serum antioxidants
categorised by J and non-J
mitochondrial haplotype
Number of subjects are in round
brackets, standard deviations are
in square brackets
Italic median, range and Mann–
Whitney U ω
*p<0.05
J haplogroup Non-J haplogroup t test mwu ω
Albumin, g/l 39.9 (12) [5.0] 40.3 (94) [3.3] 0.72
Bilirubin, μmol/l 10.4 (12) [4.4] 10.5 (94) [4.3] 0.97
Folate, μg/l 7.9 (12) [5.4] 5.6 (94) [3.5] 0.05*
Urate, μmol/l 0.24 (6) [0.13–0.56] 0.25 (44) [0.12–0.55] 0.64 ω
Vitamin A, μmol/l 2.3 (6) [1.0–3.6] 2.0 (44) [0.8–7.0] 0.89 ω
Vitamin E, μmol/l 20.3 (6) [13–32] 26.3 (44) [10.6–57.6] 0.05* ω
α Carotene, μmol/l 0.11 (6) [0.01–0.36] 0.16 (44) [0.01–1.2] 0.27 ω
β Carotene, μmol/l 0.22 (6) [0.03–2.4] 0.42 (44) [0.04–1.8] 0.73 ω
Vitamin C, μmol/l 11.5 (6) [6–59] 32.9 (28) [1–87] 0.21 ω
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p00.07). Multinominal logistic regression models 1, 2
and 3 were set up with J and non-J mitochondrial
haplotype as the dichotomous variable to include the
independent variables blood pressure, glutathione per-
oxidase activity and folate. Table 4 shows the log like-
lihood ratio model fit for each with associated χ2, p and
r2 values and shows that while all models could predict
the class of J or non-J mitochondrial haplotypes for all
three independent variables, model 3 performed best
in predicting class category for both blood pres-
sure and glutathione peroxidase activity (p00.02).
There was a suggestion that there may have been
collinearity between glutathione peroxidase activity
and folate though the r value −0.284 in the correlation
matrix was not particularly high (data not shown).
Discussion
The main finding in this cross-sectional study of BEL-
FAST octo/nonagenarians, enlisted by Senieur proto-
col was that those who carried the mitochondrial J
haplogroup had lower systolic blood pressure com-
pared to non-J haplogroups, and this trend was also
separately present in men and women who were octo/
nonagenarians. Hypertension is the single most impor-
tant risk factor for cardiovascular disease, stroke and
Alzheimers disease, all of which contribute to early
mortality, increased morbidity and poor quality ageing
(Hajjar et al. 2007). There is a large amount of evi-
dence to show that small decreases in blood pressure
can achieve important effects for public health. A
reduction in systolic blood pressure of 5 mmHg is
estimated to reduce mortality to stroke by 14 %, mor-
tality from heart disease by 9 % and all case mortality
by 7 % (Lewington et al. 2002). Although mitochon-
drial haplogroups vary geographically and ethnically
across the world, this finding in Caucasians is of
particular interest in the light of recent findings of an
association between the mitochondrial uncoupling
protein 1 and blood pressure in Korean females which
is independent of obesity and body mass index (Cha et
al. 2008) and the identification of a mutation in
mtDNA haplogroup G2a1 across three generations of
a Chinese family which was associated with female
hypertension (Luon et al. 2011).
There is increasing evidence that the various mito-
chondrial haplogroups have functional differences
which seem likely to be related to reductions in ATP
production, increased generation of reactive oxygen
species and impaired calcium buffering (Postnov
2005), all of which may be related to central sympa-
thetic central overstimulation (Postnov et al. 2007).
Early studies linked various mtDNA haplogroups
and mutations with clinical presentations associated
with Leber’s optic atrophy, muscle storage disease
and deafness, often with quite complex phenotypes
(Wallace 2005). More recent publications have begun
to show clearer links between mtDNA haplogroups
and specific disease entities, i.e. osteoarthritis and the
J mtDNA haplogroup, with J carriers having lower
biomarkers of oxidative stress compared to non-J car-
riers (Fernandez-Moreno et al. 2010), and reduced
osteoarthritic disease. There is also recent interest in
the association of mtDNA haplogroups with age-
related macular degeneration (Udar et al. 2009), where
it appears that partial and thus subclinical deficiencies
in mitochondrial energy production are associated
with J, T and U mitochondrial haplogroups which
are suggested to become more sensitive to age-
related macular damage from a possible hexane-
Fig. 2 Systolic and diastolic blood pressure categorised by
mtDNA J and non-J haplogroups for BELFAST octo/nonage-
narians with box and whisker plots showing median and 25th
and 75th percentiles, *p<0.05
Fig. 3 Systolic and diastolic blood pressure categorised by
mtDNA J and non-J haplogroups for male and female BEL-
FAST octo/nonagenarians with box and whisker plots showing
median and 25th and 75th percentiles, *p<0.05
AGE (2013) 35:1445–1456 1451
related metabolic pathway. A recent publication also
suggests that the mtDNA J haplogroup had protective
effects in modulating telomere length and nitric oxide
production in carriers (Fernandez-Moreno et al. 2011).
This finding resonated with earlier work showing that
mtDNA haplogroups had altered oxygen-metabolising
capacity in groups living at higher altitudes with
mtDNA J haplogroup carriers having reduced DNA
damage (Domínguez-Garrido et al. 2009). These stud-
ies provide increasing evidence supporting a mecha-
nistic link between reduced oxidative stress status and
carriers of the mtDNA J haplogroup. Similar findings
are mirrored in the BELFAST study where glutathione
peroxidase antioxidant enzymatic activity was lower
in both serum and whole blood in octo/nonagenarians
who carried the mtDNA J haplogroup and who also
had co-existing lower blood pressure. The work of
Rybka et al. 2011b shows similar changes with
hypertension.
Higher glutathione peroxidase activity found in
BELFAST octo/nonagenarians in association with
higher blood pressure is in keeping with suggestions
that oxidative stress plays an important patho-
physiological role in the development of hypertension
(Ceriello 2008; Lassegue and Griendling 2004; Redón
et al. 2003). Oxidation by-products are considered to
damage or inactivate endothelium-derived nitric oxide,
an important vasodilator, and as a result cause reactive
vasoconstriction. Although there is broad agreement of
a relationship between oxidative stress and essential
hypertension (Rodrigo et al. 2007), the interpretation
of evidence is far from simple. Gpx is mostly reduced
in situations where anti-oxidant stress is minimal, but
increased where there is, for example hypertensive or
cardiovascular stress linked with the inflammatory cas-
cade (Harrison et al. 2003; Rea et al. 2011). Therefore a
possible interpretation of the BELFAST data could be
that J haplogroup survivors exemplify a low anti-
oxidant stress model for Gpx and the GPx/GSH redox
re-cycling reaction. Interestingly, reduction in GPx 4
activity in knockout mice, increased lifespan in the
mice, with a mechanism relating to oxidative stress-
induced apoptosis (Qitaoran et al. 2007), suggesting
possible parallel mechanisms in humans.
The molecular pathway linking mitochondrial hap-
logroups and mutations with mechanisms and function
in hypertension has become a bit clearer as a result of
these publications and the recent work by Luon et al.
2011. Here, the tRNAmet4435A4G mutation in
mitochondrial haplogroup G2a1 was responsible for
maternally inherited hypertension across three genera-
tions of female family members in China. This mito-
chondrial mutation appears to reduce protein synthesis,
with downstream impairment of the mitochondrial res-
piratory chain function, reduction of ATP production,
increased reactive oxygen species production and en-
hanced hypertension susceptibility.
Albumin and bilirubin are the most abundant and
important non enzymatic anti-oxidants in the body
(Vítek and Ostrow 2009; Halliwell 1988) and their
equilibrium might be expected to be disturbed in as-
sociation with hypertension but we found no evidence
to support this hypothesis in BELFAST octo/nonage-
narians. We also found no changes for serum vitamin
C, although folate sometimes considered a surrogate
for Vitamin C and vegetable intake, was significantly
Table 4 Logistic regression for J and non-J mitochondrial haplogroups for Systolic Blood Pressure, Glutathione Peroxidase activity
and Folate for BELFAST octo/nonagenarians with best fit Multinominal Models 1, 2 and 3
Variables J/nonJ Coeff B SE Chi-sqare p value Exp(B) CI (95%)
Syst BP (120) 13/107 −0.05 0.02 5.69 0.017* 0.95 0.91–0.99
Gpx (65) 7/58 −0.02 0.01 4.87 0.027* 0.98 0.96–1.0
Folate (106) 12/94 0.12 0.06 3.31 0.07 1.12 0.99–1.27
Model 1 Syst BP, Gpx, Folate LR whole model fit for J/nonJ x2 9.89 p=0.02* r2=0.29 predicts 95%
Model 2 Syst BP, Folate LR whole model fit for J/nonJ x2 9.92 p=0.007* r2=0.10 predicts 87%
Model 3 Syst BP, Gpx LR whole model fit for J/nonJ x2 7.64 p=0.02* r2=0.22 predicts 93%
LR likelihood ratio
*p<0.05
1452 AGE (2013) 35:1445–1456
higher in mtDNA J haplogroup carriers. Dietary vitamin
C has been shown to increase antioxidant capacity (Cao
et al. 1998), to associate with lower blood pressure
(Myint et al. 2011; Ceriello 2008), but not to enhance
longevity (Choi et al. 2004). Although Vit E was mar-
ginally increased in J haplotype carriers, we did not find
that vitamins A and α and β carotenoids were different
across mtDNA J haplogroup categories in BELFAST
octo/nonagenarians unlike Semba et al. 2006 who dem-
onstrated that low carotenoid micronutrients predicted
frailty and mortality in community-living older women.
However, our groups were small and follow-up to date
has been limited.
Important limitations of this research are the cross-
sectional nature of the BELFAST study and the numb-
ers which may have reduced the power. However,
90 year olds are both the fastest growing sector of
present day populations and the group about whom
we know relatively little medically, socially and eco-
nomically. It can be argued that they are of special
interest because of their extreme age and because in
this study they were well categorised by Senieur status
(Rea et al. 2009; Rea 2010; Lighthart et al. 1984).
Studies in this age group are extremely challenging
because of perceived or real frailty and the understand-
able concern of the subjects themselves, relatives,
researchers and Ethical Committees not to exploit, tire
or over-ride the autonomy of the subject group
(Samelson et al. 2008). For these reasons, some subjects
contributed only anthropometric measurements or a
limited amount of blood. Furthermore, catalase and
superoxide dismutase have not been assessed as con-
tributors to the enzymatic antioxidant profile in BEL-
FAST octo/nonagenarians, and this leaves an important
unknown aspect of the total anti-oxidant profile.
The findings in the BELFAST study are very pre-
liminary but are potentially interesting. They will need
to be replicated but do provide some support for the
idea that carriage of the mtDNA J haplogroup may be
associated with a lower blood pressure profile. The
associated altered antioxidant profile, which has been
identified could also play a role in a longevity pheno-
type (De Benedictis et al. 1999; Ross et al. 2001;
Niemi et al. 2003), though as has been suggested by
others, the J mitochondrial haplogroup may act out a
different role depending on its associated nuclear and/
or dietary or life-style microenvironments (Gomez and
Hagen 2012). In terms of mechanisms Marcuello et al.
2009 recently described J haplogroup carriage in male
Spanish subjects to be associated with a lower effi-
ciency of the electron transport chain, diminished ATP
and reactive oxygen species production suggesting
possible decreased oxidative damage with this hap-
logroup. In an interesting follow-up study, this group
noted that mtDNA haplogroup differences in oxygen
energy production were negated by exercise, a clear
example of a link between molecular pathways and
environmental and life-style behaviours (Martínez-
Redondo et al. 2010), while Rose et al. 2010 suggest a
link between mitochondrial mutations and frailty
markers. Rea et al. 2011 also suggest a link between
hypertension, anti-oxidant stress and the inflammatory
cascade related to infection. A further argument is that
the enzymatic anti-oxidant system is much more likely
to be under nuclear and/or mitochondrial genetic or
metabolic fine-tuning and so more likely to be demon-
strately changed in long-living species including man.
We found no evidence that mitochondrial haplogroup T,
which shares the same sub-root as J, was associated with
lower blood pressure as found with the J mitochondrial
group, directing attention to a possible role for T4216C,
A11251G and C15452A mutation substitutions not
shared with haplogroup T. Recent work also suggests
that the J1 and J2 subtypes of mtDNA J haplogroupmay
have functional differences. These findings need to be
replicated in ongoing studies of ageing such as the
Genetics of Healthy Ageing study (Franceschi et al.
2007; Rose et al. 2010; Skytthe et al. 2011) where there
is adequate power and sample availability to link
mitochondrial haplotypes with lifestyle phenotypes.
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